Psoriasis is an inflammatory skin disease that is not contagious. Here, the immune system attacks the body's own tissue. A team led by Prof. Dr. Tamara Kopp from MedUni Vienna has successfully used antibodies to combat the symptoms of psoriasis in a clinical trial.

Treatment of psoriasis

As reported by kleinezeitung.at, dermatologist Prof. Tamara Kopp from the JUVENIS beauty center in Vienna was able to show in a new study that the targeted blocking of a messenger substance in the immune system (interleukin-23/IL-23) significantly alleviates the symptoms of psoriasis.

A total of 77 patients (with moderate to severe symptoms of psoriasis) were injected with different amounts of the antibody "Tildrakizumab" or a placebo preparation in a study. The skin of the patients treated with high doses was up to 100 percent free of the symptoms of psoriasis.

The phase II study has already been successfully completed and is currently in the clinical phase III study. The dose has already been determined and it is no longer administered intravenously, but only under the skin (subcutaneously). The study is now in the final stage before possible approval.

Further treatments for healthy skin in Vienna at JUVENIS

In addition to treatments for healthy skin in Vienna, JUVENIS offers other services relating to health & prevention, radiance & posture and outer beauty that will make you look radiant and enhance your well-being.

The article can be read in the latest edition of kleinezeitung.at.
The study:"Clinical improvement in psoriasis with specific targeting of interleukin-23," Nature (March 9, 2015; doi: 10.1038/nature14175).